Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3

Who knows muya. Company has been as quite as former portfolio manager poster bingo after telling everyone to load up at 11c as it will be their last chance then disappear.
heard nothing on why spirosonic fda was rejected, ventitest progress , how new south east Asia distributor has progressed, koneksa, ehealth app , new US distributor progress and on and on it goes.
must say the quarter was better then I thought it be. Slight improvement on last. The bid centre site has gone quite for entire month with no new at all which disappoint. Dec month was extremely good though so should flow through to revenue in next or following quarter maybe so could be a strong uptick in revs in next 2 quarters.
maybe I wrong with assumption.
commentary was blah blah and nothing to make anyone want to buy .
more products- more distributors- more sales and revenues. Still waiting .